Expertise in
11
conditions

Liora Harel

Tel Aviv, TA, IL 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
11
conditions
Tel Aviv, TA, IL 

Overview

Liora Harel practices practicing medicine in Tel Aviv, Israel.

Ms. Harel is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Rheumatic Fever, and PFAPA.

She is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Tel Aviv, TA, Israel
Other Locations
Petah Tiqwa, M, Israel
Ramat Aviv, TA, Israel
59 Tshernichovski Street, Kfar Saba, M 44281, Israel
Et Taiyiba, M, Israel
Petach Tikvah, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Enrollment Status: Recruiting
Publish Date: August 27, 2026
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
View 2 Less Clinical Trial

64 Total Publications

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.
What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.
Journal: Journal of scleroderma and related disorders
Published: April 15, 2026

Frequently Asked Questions about Liora Harel

Is Liora Harel a top-rated expert for Scleroderma?

MediFind is an objective health platform that identifies experts based on real-world data. Liora Harel is classified as an Distinguished expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Liora Harel participate in research or clinical trials?

Yes. Liora Harel has published 64 articles and abstracts on conditions like Scleroderma. You can view a list of Liora Harel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Harel's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 34 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile